Gabriel Barsotti, MD, MHA

2024

• Rationale and Design of a Phase 2, Double-blind, Placebo-controlled, Randomized Trial Evaluating AMPK-activation by Metformin in Focal Segmental Glomerulosclerosis

  Gabriel C. Barsotti, Randy Luciano, Ashwani Kumar, Kristin Meliambro, Vijayakumar Kakade, Joji Tokita, Abhijit Naik, Jia Fu, Elizabeth Peck, John Pell, Anand Reghuvaran, E.M. Tanvir, Prashant Patel, Weijia Zhang, Fan Li, Gilbert Moeckel, Sudhir Perincheri, Lloyd Cantley, Dennis G. Moledina, F. Perry-Wilson, John C. He, Madhav C. Menon, Rationale and Design of a of a Phase 2, Double-blind, Placebo-controlled, Randomized Trial Evaluating AMPK-activation by Metformin in Focal Segmental Glomerulosclerosis, Kidney International Reports, 2024, , ISSN 2468-0249, https://doi.org/10.1016/j.ekir.2024.02.006. (https://www.sciencedirect.com/science/article/pii/S2468024924000950)

  Peer-Reviewed Original Research In Press